Study S001359

Identifying Therapeutic Mechanisms for Incretin-Based Treatment in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07554638
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 50
Start: 2026-08-07
Primary completion: 2029-04
Lead sponsor: Columbia University
Conditions: Heart Failure, Diastolic; Heart Failure With Preserved Ejection Fraction; Obesity
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Plasma volume [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.